Table 2 Treatment and responses
ID | Sorafenib treatment time (weeks) | Mean daily dose (mg) | Response during sorafenib | Time to tumor progressa while waiting for Ltx (weeks) |
|---|---|---|---|---|
1 | 52.1 | 382 | PD | 28 |
2 | 5.1 | 433 | SD | 20 |
3 | 23.3 | 145 | PD | 12 |
4 | 21.0 | 524 | SD | – |
5 | 23.1 | 431 | PD | 20 |
6 | 6.0 | 210 | SD | 12 |
7 | 23.3 | 798 | PD | 12 |
8 | 27.1 | 412 | PD | 20 |
9 | 11.4 | 230 | SD | – |
10 | 0.6 | 700 | SD | – |
11 | 3.3 | 522 | SD | – |
12 | 24.3 | 561 | SD | – |